Supporting Your Product’s Placement on NHI Reimbursement Price Tariffs

Launching drugs in Japan require knowledge of the application process for National Health Insurance (NHI) reimbursement pricing. Our consultants can guide you through the process and requirements, providing strategic support in the negotiation with health authorities to be part of the NHI pricing scheme.   We provide assistance with navigating the NHI reimbursement price application as part of our support efforts for overseas pharmaceutical companies, academia, and venture firms seeking to market orphan drugs.

Our Edge in NHI Reimbursement

Experience in supporting MAH in acquiring NHI reimbursement price listings in Japan

  • Our regulatory affairs team provides support for MAH to negotiate NHI price with Ministry of Health, Labour and Welfare.


  • Pre-approval strategic planning for anticipated drug price
  • Price listing support for post-drug approval in Japan
  • Supporting preparation of the application documents and negotiation for partial or full coverage on NHI price listing for new drugs
market authorization

Marketing Authorization Holder (MAH)


Regulatory Affairs

Consulting Services

Consulting Services